MidCap T ApS: Financial statements 2024
CVR: 40238581
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MidCap T ApS (CVR 40238581) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -109,000 and a net result of DKK 621,000 compared with DKK 186,000 the year before. Equity in the 2024 report amounted to DKK 198,522,000. The solvency ratio was 98.6%.
- Gross Profit
- DKK -109,000
- Profit/Loss
- DKK 621,000
- Equity
- DKK 198,522,000
- Total Assets
- DKK 201,411,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -109 t. | 621 t. | 198.5 mio. | - |
| 2023 | - | -13 t. | 186 t. | 144.5 mio. | - |
| 2022 | - | -13 t. | -11 t. | 119.3 mio. | - |
| 2021 | - | -19 t. | -35 t. | 119.3 mio. | - |
| 2020 | - | -158 t. | -32.2 mio. | 119.4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of November 25, 2024, Mads Bødtcher-Hansen has joined the board of directors of MidCap T ApS.
As of October 24, 2024, ORIFARM GENERICS HOLDING A/S is registered as an owner of MidCap T ApS with an ownership share of 25%.
As of October 24, 2024, MBH ApS is registered as an owner of MidCap T ApS with an ownership share of 20%.
As of October 24, 2024, TOPCAP T ApS is registered as an owner of MidCap T ApS with an ownership share of 25%.
As of October 23, 2024, Janus Investering ApS is registered as an owner of MidCap T ApS with an ownership share of 5%.
As of October 23, 2024, Svane Capital ApS is registered as an owner of MidCap T ApS with an ownership share of 5%.
MidCap T ApS has published its annual report for 2023. Gross profit came to DKK -13,000, and the net result was DKK 186,000.
About MidCap T ApS
MidCap T ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Martin Jørgensen. The board consists of Ulrik Kronborg Markussen (chair), Claus Svane Gleerup, Mads Bødtcher-Hansen and Martin Jørgensen. The company's owners include ORIFARM GENERICS HOLDING A/S, MBH ApS and Janus Investering ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -16,000 and a net result of DKK -24,871,000 compared with DKK 621,000 the year before. Equity in the 2025 report amounted to DKK 173,650,000.